Sat, Aug 2, 2014, 5:39 AM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Omeros Corporation (OMER) Message Board

rrtzrealmd 107 posts  |  Last Activity: Jul 29, 2014 10:36 AM Member since: Aug 24, 2011
  • rrtzrealmd rrtzrealmd Jul 8, 2014 9:48 AM Flag

    ...oh, wow!...that leaves me breathless!!!...from LAUGHING!!!...the guy only took home 4.5 MILLION dollars in compensation -- NOT including benefits -- in 2013!!!...and you're wound up because he parted with 16 grand to buy some of his own company's stock????...hoo-boy!...doesn't take much to get you excited, huh?...HAW!!!...

  • Reply to

    no update from mnkd? a good thing..

    by protectdeeznutz Jul 8, 2014 9:02 AM
    rrtzrealmd rrtzrealmd Jul 8, 2014 9:40 AM Flag

    ...."no update...a good thing" -- oh, definitely!!!...cuz when they DO update and tell you that despite their best efforts they haven't been able to find a suck...uhhhh...a partner!...

    ...oh, no, wait!...that's not what they'll say!...how silly of me!...no, what' they'll SAY is that after due consideration and careful review of strategic options, they have decided that it would be in the best interests of the company and its stockholders that MKND pursue marketing of Afrezza independent of any burdens imposed by a partnership...

    ...yeah, it''ll be something like that!...I betcha!...I just betcha!...and then, of course, comes the secondary offering to pay for that, etc, etc, etc....

  • ...for accuracy...the FDA recently made accuracy requirements stricter -- a glucometer must read within 15% of true glucose levels 95% of the time for blood glucose over 100...the old standard was within 20%...given the Dario is now what -- 10 plus YEARS old, one has to wonder whether it can meet these new requirements...

    ...for comparison, the VASTLY SUPERIOR Bayer Contour USB met the new requirements even before the final standards were announced...

    ...also, Dario wasn't included in Freckmann et al's "System accusacy evaluation of 27 blood glucose monitoring systems" from 2010....and DRIO's stupid owner's manual on their website has a section called "accuracy" which, oddly enough, provides NO INFORMATION about accuracy!...somehow I doubt this antique device will pass muster in the old "accuracy" department....

  • rrtzrealmd rrtzrealmd Jul 8, 2014 9:02 AM Flag

    ...an "estimate of what this worth"???...uhhhhh, how about ZERO?...good enough for you?...think "socialized medicine" -- for example:

    "Diabetes UK is concerned that people with diabetes are experiencing restrictions in their access to test strips and meters...We conducted a survey to further investigate the situation following an increase in calls to the Careline and Advocacy teams about this issue.

    The survey found that 39 per cent of respondents had either been refused a prescription of blood glucose test strips or had their prescription restricted – many in the last year. Of those who had experienced restrictions, 58 per cent were people with Type 1 diabetes and 40 per cent with Type 2 diabetes."

    Nevertheless, you go to the "farlamedical" and compare prices...you see the Dario costs about 18E versus 33E for the VASTLY SUPERIOR Bayer Contour USB...but wait!...you check the Bayer website and see that there you can get a Contour USB absolutely FREE!...so much for THAT cost comparison...

    ...then see what the test strips sell for -- there's where the REAL dough lies...you see that Contour's test strips cost about 17E for 50 while Dario's cost about 30E for 100 -- sort of competitively priced...but wait!...you go to the Bayer website again and see that they have the "Contour Choice Program" which reimburses you around $35 per prescription...so much for that comparison as well!...

    ...then again, who cares?...because it's SOCIALIZED medicine and you'll be lucky to see a shilling's worth of profit regardless!...

  • Reply to

    No news is good news

    by juicyjuice10001 Jul 7, 2014 6:53 AM
    rrtzrealmd rrtzrealmd Jul 8, 2014 8:25 AM Flag

    ...yeah, right!...you only been waiting a DECADE or so for "the deal," what's another DECADE or two, right?...

  • rrtzrealmd rrtzrealmd Jul 7, 2014 7:01 PM Flag

    ...gee, what a bunch of suckers!"...total lack of transparency ..."highly unusual"???...not really...not if you ain't got no "potential partners," it ain't!....remember this:

    "We made substantial progress toward a definitive agreement with a lead potential partner; however, as the discussions progressed, we came to believe that it would be more productive to complete a partnership after we have received a response from the United States Food and Drug Administration, or FDA, regarding our new drug application for AFRESA."

    ...that was from 2009!....FIVE YEARS go!...hmmmmmm, "WE came to believe"?...say what, Mr. Analyst:

    "In fact, negotiations with the partner were so advanced that MNKD ceased talking to other potential partners. Term sheets apparently were set but the partner reportedly withdrew after review with its regional commercial managers, who were not included in the negotiations until the end but ultimately raised objections regarding the deal."

    ...oh, yeah!...right!..like you wait until a deal is almost completed, and THEN ask for an opinion from your "regonal commercial managers" -- yeah!..uh-huh!...gotcha!...hey, probably better than just coming out and confessing there were NO "negotiations" to begin with, right?...

  • rrtzrealmd by rrtzrealmd Jul 3, 2014 11:25 AM Flag

    ..."attractive valuation" at $5 back in September, she oughta be doing multiorgasmic backflips today, huh?...but alas, no, NOW she says it's worth only $2 a share...actually, Linda, it's not worth the price of a price of a used tampon, but I suspect you already know that...HAW!...

  • Reply to

    2Q earnings / Vic's performance

    by aeroval Jul 1, 2014 12:10 PM
    rrtzrealmd rrtzrealmd Jul 2, 2014 11:16 AM Flag

    ...his base pay is only $350,000...last year he got a bonus/incentives of $560,000...on top of that he was given an option award worth about 3 million...average CEO compensation for Russell 3000 companies is $5,250,000...so on average, he's actually UNDERcompensated...

  • Reply to

    Are diabetics "excited"?

    by rrtzrealmd Jul 1, 2014 12:08 PM
    rrtzrealmd rrtzrealmd Jul 1, 2014 9:34 PM Flag

    I'm going to quit talking to you...you got me to look at MNKD and when I saw what some of those idiots on seekingalpha were trying to claim, I felt compelled to offer an alternative view and there just isn't time to try and rebuke all the biotech scams currently trading...and that worries me because the last time biotechs got this "stupid" was back around 1999-2000 and the subsequen "correction" wasn't pretty -- to say the least...

    ...however, since my IMMR decided to bolt higher the past couple of days and I'm feeling generous, I'd say ARO has possibilities...minimal debt, goodwill, and intangibles...don't know what the company's excuse is for going from making two bucks a share 3 years ago to losing money this year...has an interested investor in Sycamore...so it's worth considering, but given what Sycamore did with Talbot's I'd be leery of risking much...but I haven't studied the 10Qs so maybe there's more than meets the eye...

  • rrtzrealmd by rrtzrealmd Jul 1, 2014 12:08 PM Flag

    Well, afrezza has been running around the treadmill for what -- 7 - 10 YEARS? So it's safe to conclude ALL diabetics know about it, okay? Now, google "diabetes forum afrezza" and cruise through a few to get some idea how excited they are about the approval. Random quotes:

    "Lungs being one of the more vital body functions, I can't imagine agreeing to a new drug not knowing the long term effects."

    "I just don't understand how it could be precise enough for use with type 1."

    "...my mind just does not go there. Maybe it's because I'm asthmatic..."

    The most excitement I could find was the father of a kid who was happy to "welcome a new tool"! Too bad it'll be another THREE YEARS plus who knows how many millions (billions?) of dollars more before his kid even has a chance to try it!

    Indeed, I couldn't even find afrezza mentioned on several forums!

    Face it! Diabetics could care less about afrezza! The ONLY people "excited" about afrezza are stockbrokers and stock pumpers. Why? Because they want to selI STOCK and could less aboout the reality in store for afrezza.

  • ...The thrill is gone away, You know you've done me wrong, baby...And you'll be sorry someday...HAW, HAW, HAW!!!!

  • Reply to

    Is there a corporate lawyer here?

    by antimatter0007 Jun 27, 2014 11:57 AM
    rrtzrealmd rrtzrealmd Jun 27, 2014 2:31 PM Flag

    ...depth?...when you're talking about MNKD, who needs depth?...

  • Reply to

    Is there a corporate lawyer here?

    by antimatter0007 Jun 27, 2014 11:57 AM
    rrtzrealmd rrtzrealmd Jun 27, 2014 2:27 PM Flag

    ...get real!...they can't disclose names because there AIN'T ANY!...never have been, likely never will be!..."partners" are just part of the usual biotech hype train that pulls out of the station whenever the company is looking to pump its stock price -- as in, before a secondary, for example...all the potential partners already know what the company has and know what its REALLY worth -- result: no partners...

  • Reply to

    Drug efficacy and side effects datas

    by tanweikate Jun 22, 2014 8:21 AM
    rrtzrealmd rrtzrealmd Jun 23, 2014 8:00 PM Flag

    ...gee, are you referring to the PRELIMINARY results reported for all of SIX patients who were evaluated in a PHASE 1B trial in Australia, New Zealand, and that mecca of medical progress, SPAIN?...not to mention that it was not a blinded trial and how much you wanna bet there were some financial "incentives" for the parties involved?...

    ...regardless, you're still looking at a minimum of 4-5 YEARS before even the hope of a marketable product might rear its head...

  • Reply to

    One little, two little...

    by rrtzrealmd Jun 23, 2014 11:03 AM
    rrtzrealmd rrtzrealmd Jun 23, 2014 7:34 PM Flag

    ...oops!...my mistake -- IGAP, not IDAP...probably laughing to hard at the time!...

  • rrtzrealmd by rrtzrealmd Jun 23, 2014 11:03 AM Flag

    ...three little Israeli scams!...four little, five little...well, you get my point...guess what -- I found another one this am!...I think I mentioned DRIO and its antique glucometer sometime previously, and this morning what did I find but a company called -- are you ready for this? -- "Integrity Applications"!!!...HAW!...is that rich or what?!

    ...anyway, IDAP has this marvelous non-invasive glucose monitoring system...unfortunately, they have hardly ANY money -- a million bucks or so -- so getting approvals and marketing are going to be kinda tough...and they also don't have any partners or, for that matter, anyone who appears even remotely interested in partnering...

    ...so, hey, maybe some of you suck...uhhhhhhhhhh..."speculative" investors might wanna bop over there help'em out!...why, heck, I worth they're worth every bit as much as Orascam!...HAW!!!...

  • ...goodness, it seems like every other company I stumble over is an Israeli SCAM!...let's see, a million dollars in cash?...oh, yeah, that'll go a LONG way towards developing and marketing a product!...no partners???...no one even showing an interest in partnering???????...but!...but!!...it's such a "great" device -- massive potential, everyone'll want one!...now, buy my stock -- plueeeeeze!!!...HAW!!!...

  • rrtzrealmd by rrtzrealmd Jun 23, 2014 9:46 AM Flag

    Come on!...with 22 million shares?...market makers getting lazy or what?...

  • Reply to

    Notch Signaling Article 2011

    by stocksifuca Jun 20, 2014 8:53 PM
    rrtzrealmd rrtzrealmd Jun 23, 2014 9:40 AM Flag

    ...I hate to be redundant, but borrowing from my earlier post on the subject, was GSK "naive" when it invested in EXEL's XL228, XL820, and XL844 -- a deal which GSK TERMINATED three years later?...

    ...or was Genentech "naive" when it signed on with EXEL to develop notch inhibitors in 2005?...that's right, norch inhibitors!...by that time EXEL had ALREADY been working on the notch pathway for EIGHT YEARS!...did you know that one of the founders of EXEL -- Dr. Artavanis-Tsakonas -- is one of the big guns in notch research; you can google his name to find his notch lab at Harvard...

    ...after you do that, go over to EXEL's website and read about their current partners...won't see no Genentech...won't see no mention of notch anywhere...but they still got a BUNCH of other partners though...

    ...EXEL even has an APPROVED drug!...yessir, cometriq started on the market in the first quarter of 2013...last quarter EXEL reported revenues of a whopping 4.9 MILLION dollars from cometriq...and GSK gets a whopping THREE per cent of that!...nope, no naivety there!...

    ...were investors "naive" to pay up to $45 (yes, FORTY FIVE dollars) per share back in 2000...were they naive to hold the stock as it steadily sandk over the next fourteeen years?...and were they naive to buy stock in the secondary in January for $8 a share?...only to turn around and see the stock tank to THREE BUCKS only a couple of months later when EXEL announced results of an interim analysis of one of their trials?...

    ...and now any any not naive EXEL shareholder can point proudly to his whopping twenty five CENTS a share in equity while the stock trades at all of $3.50 per share!...ahhhhh, who would've dreamed of such enrichment...

  • ....SCAM biotech!...I swear, these things breed like rabbits, don't they?...HAW!...

OMER
13.57-0.04(-0.29%)Aug 1 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.